Cargando…
Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what’s new and what’s enough
Historically, non-small cell lung cancer (NSCLC) is divided into squamous and nonsquamous subtypes based on histologic features. With a growing number of oncogenic drivers being identified in squamous and nonsquamous NSCLC, this malignancy has been recently divided into several distinct subtypes acc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593374/ https://www.ncbi.nlm.nih.gov/pubmed/26187152 http://dx.doi.org/10.1186/s40880-015-0036-4 |